Knowledge and Follow-up of Vitamin B9 Supplementation Recommendations for Women in the Periconceptional Period to Prevent Neural Tube Closure Defects: a Study Conducted With Health Professionnals and Women Who Have Just Given Birth in Rennes CHU.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,284
- 试验地点
- 1
- 主要终点
- To assess the knowledge and the follow-up of vitamin B9 supplementation recommendations for women in the periconceptional period to prevent neural tube closure defects.
研究概览
简要总结
The study objective is to assess the knowledge and the follow-up of vitamin B9 supplementation recommendations for women in the periconceptional period to prevent neural tube closure defects. It will be conducted with health professionnals and women who have just given birth in Rennes CHU.
This study aimes to assess men's and women's knowledge of the need to take vitamin B9 supplementation in women in the periconceptional period and the reasons why this supplementation is carried out or not, in order to target our future prevention campaign.
This will allow comparing the results before and after the prevention campaign.
详细描述
Neural tube closure defects are among the most common birth defects. They are also called Spina Bifida or spinal dysraphism. According to the latest epidemiological studies in Europe based on the EUROCAT register (1991-2011), the prevalence of neural tube closure defects (including spinal dysraphisms as well as anencephaly and encephalocele) at birth is estimated at 9.105/10000 births in Europe (95% CI 8.94 to 9.27) and 12.02/10000 births in France.
The effectiveness of vitamin B9 (or folic acid or folate) supplementation in the periconceptional period on reducing the prevalence of neural tube closure defects has been widely demonstrated.
In France, the HAS (public health agency) recommends taking vitamin B9 between 1 month before and 2 months after conception, at a dose of 0.4 mg per day (5 mg per day in case of risk factors) since 2009. However, the proportion of women taking folic acid during periconceptional period is estimated at 1%.
The spina bifida - dysraphisms centre of the University Hospital Center of Rennes wishes to implement a campaign to prevent neural tube closure defects by supplementing with vitamin B9 during periconceptional period.
This study aimes to assess men's and women's knowledge of the need to take vitamin B9 supplementation in women in the periconceptional period and the reasons why this supplementation is carried out or not, in order to target our future prevention campaign.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Questionnaires to women who have just given birth:
- •Women >= 18 years old, hospitalized in obstretric wards in Rennes CHU
- •Having given birth within 2 weeks of completing the questionnaire
- •Questionnaires to hospital professionals:
- •People working at the Rennes CHU
- •Using a standard email address...@chu-rennes.fr
排除标准
- •Questionnaires to women who have just given birth:
- •Non-French-speaking
- •Cognitive impairment preventing understanding of the questionnaire and self-reporting
- •Person under legal protection
- •Person subject to a measure to safeguard justice
- •Refusal to participate
- •Questionnaires to university hospital professionals:
- •Refusal to participate
结局指标
主要结局
To assess the knowledge and the follow-up of vitamin B9 supplementation recommendations for women in the periconceptional period to prevent neural tube closure defects.
时间窗: the inclusion day
Proportion of people who were or had a spouse supplemented during her last pregnancy.
次要结局
- To describe the type of B9 vitamin supplementation taken by women before and during pregnancy (alone or in a multivitamin supplement) and the modalities of intake (dosage, frequency, duration before and during pregnancy, etc.)(the inclusion day)
- To assess the proportion of people who are aware of the need for vitamin B9 supplementation during the periconceptional period.(the inclusion day)
- To understand why women do not take any B9 supplementation : information not known, pregnancy not planned, refusal to take it despite a medical prescription, forgetfulness.(the inclusion day)
- To understand how respondents were informed of the value of this supplementation (through their studies, through a health professional, medias, their entourage…)(the inclusion day)